Beta-Blockers Killed 800,000 in 5 Years: “Good Medicine” or Mass Murder?

Most people assume that scientific integrity is somehow assured; that there are safeguards along the way, preventing fraudulent research from harming patients. Unfortunately, scientific misconduct has become a very serious and widespread problem that threatens the entire paradigm of science-based medicine—unless changes are made. Again and again, papers assessing the prevalence of scientific fraud and/or the impact this is having shows that the situation is dire and getting worse. In short, we have lost scientific integrity, and without it, “science-based medicine” is just a term without substance. Conflict of interest is another pervasive problem within the research field, and the featured article highlights a case that contains both. Beta-blockers are drugs commonly used in the treatment of high blood pressure and congestive heart failure. They work primarily by blocking the neurotransmitters norepinephrine and epinephrine (adrenaline) from binding to beta receptors, thereby dilating blood vessels, which reduces your heart rate and blood pressure. Until recently, the European Society of Cardiology (ESC) also recommended using beta-blockers in patients undergoing non-cardiac surgery. A recent article in Forbes Magazine highlights how medical guidelines based on questionable science may have resulted in the death of hundreds of thousands of patients in just a few years: “Last summer, British researchers provoked concern when they published a paper raising the possibility that by following an established guideline UK doctors may have caused as many as 10,000 deaths each year,” Larry Husten, editorial director of WebMD professional news, writes. Now, they have gone a step further and published an estimate that the same guideline may have led to the deaths of as many as 800,000 people in Europe over the last five years… The 800,000 deaths are comparable in size to the worst cases of genocide and mass murder in recent history.”

New Cholesterol Treatment Guidelines Could Double the Number of People on Dangerous Statins—Including Perfectly Healthy People

One in four Americans over the age of 45 currently take a statin drug, despite the fact that there are over 900 studies proving their adverse effects, which run the gamut from muscle problems to increased cancer risk. Now, new treatment guidelines for high cholesterol will likely DOUBLE the number of Americans being prescribed these dangerous drugs, bringing the total to an estimated—and staggering—72 million people! 12 of the 16 panel members of the new guidelines are affiliated with more than 50 different drug companies, many of which have a financial interest in the outcome of this report.

A Pox on Cholesterol Lowering Drugs: Statins Raise Herpes Zoster (Shingles) Risk

A new study published in the journal Clinical Infectious Diseases reveals an association between statin drug use and increased risk of herpes zoster (shingles). Researchers from St. Michael's Hospital, Ontario, Canada, conducted a population-based retrospective cohort study of Ontario residents 66 years of age or older, with a study period of thirteen years. They matched 494,651 individuals treated with a statin to an equal number of individuals not treated with one. In the main analysis, the rate of herpes zoster was higher among users of statins relative to nonusers of these drugs.

Dr. Brownstein on New Cholesterol Guidelines: Fugetaboutit

This week, the new guidelines on preventing heart disease were released by the American Heart Association and the American College of Cardiology. The media reported widely about this. Now, for most people, monitoring LDL-cholesterol and total cholesterol levels is not indicated. If your risk of developing cardiac disease is over 7.5% over a ten year period, then statins are recommended. The risk can be calculated by going to the American Heart Association website and plugging in your cholesterol and HDL-cholesterol numbers as well as your age and whether you smoke or not. It is hard for me to believe that this is where modern medicine is at. I guess nobody needs to see a health care professional anymore—just put your numbers in and if you have a 10-year heart attack risk of >7.5%,then you must take a statin for the rest of your life. I have one word for this nonsense: fugetaboutit. People do not get vascular events from a lack of a statin medication. Vascular events occur from a myriad of reasons including eating a poor diet, dehydration, as well as nutrient and hormonal imbalances. Don’t be scared about the media headlines. As you become more educated you will be more comfortable making your health care decisions.

Cholesterol Numbers Meaningless, but FDA to Approve New Class of Cholesterol-lowering Drugs Anyway

Recently, the latest guidelines (issued by the American Heart Association and the American College of Cardiology) on preventing cardiovascular disease were launched in the US, with a great blare of publicity. The key message was that targets for lowering cholesterol levels are now gone. Don’t worry about cholesterol levels! This is a remarkable U-turn and not only that. What they are saying, in effect, is that lowering LDL is of no use at all. So you might think that the logical next step is that fewer people should be taking statins. Yet weirdly the guidelines now recommend that far more people start to take statins. Perhaps another forty million in the US alone.

CoQ10 versus Ubiquinol – What You Need to Know, Especially if You Take Statins

Coenzyme Q10 is used for energy production by every cell in your body, and also helps protect against cellular damage from free radicals. CoQ10 is especially important if you’re taking a statin drug as statins deplete your body of CoQ10, thereby speeding up progression of heart disease. Ubiquinol is the reduced form of CoQ10 – the effective form your body naturally uses to transfer free electrons – and research shows that this reduced form is superior for your health in a number of ways, primarily due to its superior bioavailability if you’re over 25. CoQ10 has been available for many decades, but the reduced version, ubiquinol, has only been commercially available for about six years. Prior to that it could only be made for research studies. There are well over 100 studies supporting its use and demonstrating its many health benefits, including its beneficial effect on statin-induced myalgia and other diseases rooted in mitochondrial dysfunction. Studies have demonstrated that ubiquinol has a positive effect on: inflammatory processes, septic shock (which is also associated with mitochondrial dysfunction), cardiac arrest and stroke recovery, and periodontal disease (including gingivitis and dry mouth).

ABC Australia Exposes Cholesterol-lowering Statin Drug Scam and Pharmaceutical Criminal Activity

ABC News in Australia has done an incredible investigative report on cholesterol-lowering statin drugs, daring to expose organized crime in the pharmaceutical industry in the U.S. This is an area where no mainstream media outlet in the USA dares to go, due to the influence of the pharmaceutical industry. In this excellent investigative documentary, cardiologists are interviewed to reveal the fraud of cholesterol-lowering statin drugs, and the criminal activity that has allowed this class of drug to become the best-selling class of drugs all-time. Some of the top cardiologists in the U.S. have stated that there is not one single study showing that people who take statins will actually live longer. This fraud is now coming out into the open. After ABC Australia aired Part 1, The Heart of the Matter, last week, Australia’s top medicine safety expert, Emily Banks, urged ABC not to air the follow-up, because it might encourage people to go off their anti-cholesterol statin drugs. “If people stop using their statins . . . it’s very likely that it will result in death.” But those scare tactics and attempts at censorship failed, and below is Part 2 as it was aired in Australia, and is now available for the world to watch. If you or someone you know are prescribed a cholesterol-lowering statin drug, you would do well to invest 30 minutes of your time to watch this investigative report. You are not likely to learn this information from your doctor, and it could literally change your life.

Study: Lifestyle Trumps Cholesterol-lowering Statin Drugs for Primary Heart Attack Prevention

A review of the published statin research revealed a categorical lack of evidence to support the use of statin therapy in primary prevention of heart attacks. Statins may actually increase cardiovascular risk in women, the young and people with diabetes. The cholesterol-lowering drugs are also linked to an increased risk of cataracts, memory impairment, diabetes, erectile dysfunction and over 300 adverse health effects. Lifestyle changes were far more effective, and safer, for primary heart attack prevention than statin drugs.

Statin Drugs Being Tested on Critically Ill Patients

In a recent article published in JAMA, critical ill patients underwent statin drug testing because it was thought that statin therapy may decrease the mortality of ICU ventilator-assisted patient. In the end, more people died in the statin group than in the placebo group. Who in their right mind would think that critically ill patients would get better by poisoning a crucial enzyme? Keep in mind that we cannot live without adequate amounts of cholesterol.

Cholesterol Drugs Linked To Eye Damage, JAMA Study Confirms Anew

A new study published in JAMA Ophthalmology titled, "Association of Statin Use With Cataracts: A Propensity Score-Matched Analysis," reveals that the top-grossing, cholesterol-lowering drug class known as statins is significantly increasing the risk of cataracts within exposed populations. Statin-induced eye damage will be a surprising finding to some, especially to statin drug advocates who have argued that the purported 'antioxidant' effects of statins 'may slow the natural aging process of the lens.'